litlas
ログインアカウント作成

Eric B. Haura

2000–2025 年に発表

124
論文数
21,821
被引用数
79
h 指数
117
i10 指数

被引用数

Eric B. Haura の年別被引用数1971 年: 被引用 1 件1996 年: 被引用 1 件1999 年: 被引用 1 件2001 年: 被引用 6 件2002 年: 被引用 27 件2003 年: 被引用 58 件2004 年: 被引用 83 件2005 年: 被引用 106 件2006 年: 被引用 121 件2007 年: 被引用 169 件2008 年: 被引用 160 件2009 年: 被引用 162 件2010 年: 被引用 192 件2011 年: 被引用 203 件2012 年: 被引用 205 件2013 年: 被引用 201 件2014 年: 被引用 216 件2015 年: 被引用 239 件2016 年: 被引用 222 件2017 年: 被引用 222 件2018 年: 被引用 266 件2019 年: 被引用 732 件2020 年: 被引用 920 件2021 年: 被引用 1,001 件2022 年: 被引用 793 件2023 年: 被引用 648 件2024 年: 被引用 916 件2025 年: 被引用 473 件2026 年: 被引用 17 件1972〜1995 年は被引用が無いため表示していません1997〜1998 年は被引用が無いため表示していません2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,326 件、この内訳の 27.5%中国: 引用元論文 1,966 件、この内訳の 16.2%イギリス: 引用元論文 591 件、この内訳の 4.9%ドイツ: 引用元論文 505 件、この内訳の 4.2%イタリア: 引用元論文 493 件、この内訳の 4.1%フランス: 引用元論文 401 件、この内訳の 3.3%カナダ: 引用元論文 383 件、この内訳の 3.2%スペイン: 引用元論文 351 件、この内訳の 2.9%日本: 引用元論文 348 件、この内訳の 2.9%オーストラリア: 引用元論文 296 件、この内訳の 2.4%韓国: 引用元論文 294 件、この内訳の 2.4%オランダ: 引用元論文 250 件、この内訳の 2.1%
0%27.5%その他 23.9%

機関

分野

  • Medicine52.3%
  • Biochemistry, Genetics and Molecular Biology36.5%
  • Immunology and Microbiology5.1%
  • Chemistry1.2%
  • Computer Science1%
  • Neuroscience0.8%
  • その他3.1%

トピック

  • Lung Cancer Treatments and Mutations7.1%
  • Cancer Immunotherapy and Biomarkers3.5%
  • Cytokine Signaling Pathways and Interactions3.3%
  • Cancer Genomics and Diagnostics2.7%
  • Lung Cancer Research Studies2.6%
  • Lung Cancer Diagnosis and Treatment2.1%
  • その他78.7%

共著者

全論文

検索で開く
  1. Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial

    著者: Ben Creelan, Chao Wang, Jamie K. Teer, Eric M. Toloza, Jiqiang Yao, Sungjune Kim, Ana Marie Landin, John E. Mullinax, James J. Saller, Andreas Saltos, David Noyes, Leighann B. Montoya, Wesley Curry, Shari Pilon‐Thomas, Alberto Chiappori, Tawee Tanvetyanon, Frederic J. Kaye, Zachary Thompson, Sean Yoder, Bin Fang, John M. Koomen, Amod A. Sarnaik, Dung‐Tsa Chen, José R. Conejo-García, Eric B. Haura, Scott Antonia - Nature Medicine 2021 被引用: 421

  2. Amivantamab in EGFR Exon 20 Insertion–Mutated Non–Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study

    著者: Keunchil Park, Eric B. Haura, Natasha B. Leighl, Paul Mitchell, Catherine A. Shu, Nicolas Girard, Santiago Viteri, Ji‐Youn Han, Sang‐We Kim, Chee Khoon Lee, Joshua K. Sabari, Alexander I. Spira, Tsung‐Ying Yang, Dong‐Wan Kim, Ki Hyeong Lee, Rachel E. Sanborn, José Trigo, Kōichi Goto, Jong‐Seok Lee, James Chih‐Hsin Yang, Ramaswamy Govindan, Joshua Bauml, Pilar Garrido, Matthew Krebs, Karen L. Reckamp, John Xie, Joshua C. Curtin, Nahor Haddish‐Berhane, Amy Roshak, Dawn Millington, Patricia Lorenzini, Meena Thayu, Roland E. Knoblauch, Byoung Chul Cho - Journal of Clinical Oncology 2021 被引用: 632

  3. Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes

    著者: James McKay, Rayjean J Hung, Younghun Han, Xuchen Zong, Robert Carreras‐Torres, David C. Christiani, Neil E. Caporaso, Mattias Johansson, Xiangjun Xiao, Yafang Li, Jinyoung Byun, Alison M. Dunning, Karen A. Pooley, David C. Qian, Xuemei Ji, Geoffrey Liu, Maria Timofeeva, Stig E. Bojesen, Xifeng Wu, Loı̈c Le Marchand, Demetrius Albanes, Heike Bickeböller, Melinda C. Aldrich, William S. Bush, Adonina Tardón, Gad Rennert, M. Dawn Teare, John K. Field, Lambertus A. Kiemeney, Philip Lazarus, Aage Haugen, Stephen Lam, Matthew B. Schabath, Angeline S. Andrew, Hongbing Shen, Yun‐Chul Hong, Jian‐Min Yuan, Pier Alberto Bertazzi, Angela Cecilia Pesatori, Yuanqing Ye, Nancy Diao, Li Su, Ruyang Zhang, Yonathan Brhane, Natasha B. Leighl, Jakob Sidenius Johansen, Anders Mellemgaard, Walid Saliba, Christopher A. Haiman, Lynne R. Wilkens, Ana Fernández‐Somoano, Guillermo Fernández‐Tardón, Erik H.F.M. van der Heijden, Jin Hee Kim, Juncheng Dai, Zhibin Hu, Michael P.A. Davies, Michael W. Marcus, Hans Brunnström, Jonas Manjer, Olle Melander, David C. Muller, Kim Overvad, Antonia Trichopoulou, ­Rosario ­Tumino, Jennifer A. Doherty, Matt P Barnett, Chu Chen, Gary E. Goodman, Angela Cox, Fiona Taylor, Penella J. Woll, Irene Brüske, H‐Erich Wichmann, Judith Manz, Thomas R Muley, Angela Risch, Albert Rosenberger, Kjell Grankvist, Mikael Johansson, Frances A. Shepherd, Ming‐Sound Tsao, Susanne M. Arnold, Eric B. Haura, Ciprian Bolca, Ivana Holcátová, Vladimí­r Janout, Milica Kontić, Jolanta Lissowska, Anush Mukeria, Simona Ognjanovic, Tadeusz Orłowski, Ghislaine Scélo, Beata Świątkowska, Давид Заридзе, Per Bakke, Vidar Skaug, Shanbeh Zienolddiny, Eric J. Duell, Lesley M. Butler ほか 40 名 - Nature Genetics 2017 被引用: 794

  4. Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

    著者: Mark G. Kris, Bruce E. Johnson, Lynne D. Berry, David J. Kwiatkowski, A. John Iafrate, Ignacio I. Wistuba, Marileila Varella‐Garcia, Wilbur A. Franklin, Samuel L. Aronson, Pei-Fang Su, Yu Shyr, D. Ross Camidge, Lecia V. Sequist, Bonnie S. Glisson, Fadlo R. Khuri, Edward B. Garon, William Pao, Charles M. Rudin, Joan H. Schiller, Eric B. Haura, Mark A. Socinski, Keisuke Shirai, Heidi Chen, Giuseppe Giaccone, Marc Ladanyi, Kelly Kugler, John D. Minna, Paul A. Bunn - JAMA 2014 被引用: 1,744

  5. The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling

    著者: Eslam Mohamed, Rosa A. Sierra, Jimena Trillo-Tinoco, Yu Cao, Patrick Innamarato, Kyle K. Payne, Álvaro de Mingo Pulido, Jay K. Mandula, Shuzhong Zhang, Paul Thevenot, Subir Biswas, Sarah K. Abdalla, Tara Lee Costich, Kay Hänggi, Carmen M. Anadon, Elsa R. Flores, Eric B. Haura, Shikhar Mehrotra, Shari Pilon‐Thomas, Brian Ruffell, David H. Munn, Juan R. Cubillos‐Ruiz, José R. Conejo-García, Paulo C. Rodrı́guez - Immunity 2020 被引用: 218

  6. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability

    著者: Rosalie C. Sears, Faison Nuckolls, Eric B. Haura, Yoichi Taya, Katsuyuki Tamai, Joseph R. Nevins - Genes & Development 2000 被引用: 1,427

  7. Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

    著者: Jamie E. Chaft, Filiz Öezkan, Mark G. Kris, Paul A. Bunn, Ignacio I. Wistuba, David J. Kwiatkowski, Dwight H. Owen, Yan Tang, Bruce E. Johnson, Jay M. Lee, Gerard Lozanski, Maciej Pietrzak, Michał T. Seweryn, Woo Yul Byun, Katja Schulze, Alan Nicholas, Ann Johnson, Jessica M. Grindheim, Stephanie Hilz, David S. Shames, Chris Rivard, Eric M. Toloza, Eric B. Haura, Ciaran McNamee, G. Alexander Patterson, Saiama N. Waqar, Valerie W. Rusch, David P. Carbone, LCMC study investigators, Saiama N. Waqar, Elaine Shum, Misako Nagasaka, Marianna Koczywas, Edward B. Garon, David J. Finley, David Ross Camidge, Jennifer W. Carlisle, Justin D. Blasberg - Nature Medicine 2022 被引用: 237

  8. Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial

    著者: Byoung Chul Cho, Dong‐Wan Kim, Alexander I. Spira, Jorge Gómez, Eric B. Haura, Sang‐We Kim, Rachel E. Sanborn, Eun Kyung Cho, Ki Hyeong Lee, Anna Minchom, Jong Seok Lee, Ji‐Youn Han, Misako Nagasaka, Joshua K. Sabari, Sai‐Hong Ignatius Ou, Patricia Lorenzini, Joshua Bauml, Joshua C. Curtin, Amy Roshak, Grace Gao, John Xie, Meena Thayu, Roland E. Knoblauch, Keunchil Park - Nature Medicine 2023 被引用: 101

  9. HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma

    著者: Hong Zheng, Weipeng Zhao, Cihui Yan, Crystina C. Watson, Michael T. Massengill, Mengyu Xie, Chris Massengill, David Noyes, Gary V. Martinez, Roha Afzal, Zhihua Chen, Xiubao Ren, Scott Antonia, Eric B. Haura, Brian Ruffell, Amer A. Beg - Clinical Cancer Research 2016 被引用: 351

  10. Cell Type–specific Adaptive Signaling Responses to KRASG12C Inhibition

    著者: Hitendra S. Solanki, Eric A. Welsh, Bin Fang, Victoria Izumi, Lancia Darville, Brandon Stone, Ryan Franzese, Sandip Chavan, Fumi Kinose, Denis Imbody, John M. Koomen, Uwe Rix, Eric B. Haura - Clinical Cancer Research 2021 被引用: 100

  11. IGF-binding proteins secreted by cancer-associated fibroblasts induce context-dependent drug sensitization of lung cancer cells

    著者: Lily L. Remsing Rix, Natália J. Sumi, Qianqian Hu, Bina Desai, Annamarie T. Bryant, Xueli Li, Eric A. Welsh, Bin Fang, Fumi Kinose, Brent M. Kuenzi, Y. Ann Chen, Scott Antonia, Christine M. Lovly, John M. Koomen, Eric B. Haura, Andriy Marusyk, Uwe Rix - Science Signaling 2022 被引用: 72

  12. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis

    著者: Guilian Niu, Kenneth L. Wright, Mei Huang, Lanxi Song, Eric B. Haura, James Turkson, Shumin Zhang, Tianhong Wang, Dominic Sinibaldi, Domenico Coppola, Richard Heller, Lee M. Ellis, James G. Karras, Jacqueline Bromberg, Drew M. Pardoll, Richard Jove, Hua Yu - Oncogene 2002 被引用: 1,207

  13. Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma

    著者: Matthew B. Schabath, E A Welsh, William J. Fulp, Lieping Chen, Jamie K. Teer, Zachary Thompson, Brienne E. Engel, Min Xie, Anders Berglund, Ben Creelan, S. Antonia, Jhanelle E. Gray, Steven A. Eschrich, D-T Chen, W. Douglas Cress, Eric B. Haura, Amer A. Beg - Oncogene 2015 被引用: 445

  14. Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures

    著者: Robert Vander Velde, Nara Yoon, Viktoriya Marusyk, Arda Durmaz, Andrew Dhawan, Daria Miroshnychenko, Diego Lozano‐Peral, Bina Desai, Olena V. Balynska, Jan Poleszhuk, Kenian Liu, Mingxiang Teng, Mohamed E. Abazeed, Omar Y. Mian, Aik Choon Tan, Eric B. Haura, Jacob G. Scott, Andriy Marusyk - Nature Communications 2020 被引用: 143

  15. Src kinases as therapeutic targets for cancer

    著者: Lori C. Kim, Lanxi Song, Eric B. Haura - Nature Reviews Clinical Oncology 2009 被引用: 692

  16. Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non–Small Cell Lung Cancer

    著者: Jhanelle E. Gray, Andreas Saltos, Tawee Tanvetyanon, Eric B. Haura, Ben Creelan, Scott Antonia, Michael Shafique, Hong Zheng, Wenjie Dai, James J. Saller, Zhihua Chen, Nishan Tchekmedyian, Kristen Goas, Ram Thapa, Theresa A. Boyle, Dung‐Tsa Chen, Amer A. Beg - Clinical Cancer Research 2019 被引用: 140

  17. Phase I Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non–Small Cell Lung Cancer

    著者: Alberto Chiappori, Ben Creelan, Tawee Tanvetyanon, Jhanelle E. Gray, Eric B. Haura, Ram Thapa, Margaret L. Barlow, Zhihua Chen, Dung Tsa Chen, Amer A. Beg, Theresa A. Boyle, Julio Castro, Liza Morgan, Erick J. Morris, Mehreteab Aregay, Felipe K. Hurtado, Luigi Manenti, Scott Antonia - Clinical Cancer Research 2022 被引用: 69

  18. TGF-β–inducible microRNA-183 silences tumor-associated natural killer cells

    著者: Sarah S. Donatelli, Junmin Zhou, Danielle L. Gilvary, Erika A. Eksioglu, Xianghong Chen, W. Douglas Cress, Eric B. Haura, Matthew B. Schabath, Domenico Coppola, Sheng Wei, Julie Y. Djeu - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 被引用: 214

  19. Poziotinib in Treatment-Naive NSCLC Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-Label, Phase 2 Trial (Cohort 4)

    著者: Robin Cornelissen, Arsela Prelaj, Sophie Sun, Christina S. Baik, Mirjana Wollner, Eric B. Haura, Hirva Mamdani, Jonathan W. Riess, Federico Cappuzzo, Marina Chiara Garassino, John V. Heymach, Mark A. Socinski, Szu‐Yun Leu, Gajanan Bhat, François Lebel, Xiuning Le - Journal of Thoracic Oncology 2023 被引用: 55

  20. An immunoproteomic approach to characterize the CAR interactome and signalosome

    著者: María C. Ramello, Ismahène Benzaïd, Brent M. Kuenzi, Maritza Lienlaf-Moreno, Wendy Kandell, Daniel N. Santiago, Mibel Pabón-Saldaña, Lancia Darville, Bin Fang, Uwe Rix, Sean Yoder, Anders Berglund, John M. Koomen, Eric B. Haura, Daniel Abate‐Daga - Science Signaling 2019 被引用: 155

  21. Proteogenomic landscape of squamous cell lung cancer

    著者: Paul A. Stewart, Eric A. Welsh, Robbert J.C. Slebos, Bin Fang, Victoria Izumi, Matthew Chambers, Guolin Zhang, Ling Cen, Fredrik Pettersson, Yonghong Zhang, Zhihua Chen, Chia‐Ho Cheng, Ram Thapa, Zachary Thompson, Katherine Fellows, Jewel M. Francis, James J. Saller, Tania Mesa, Chaomei Zhang, Sean Yoder, Gina M. DeNicola, Amer A. Beg, Theresa A. Boyle, Jamie K. Teer, Y. Ann Chen, John M. Koomen, Steven A. Eschrich, Eric B. Haura - Nature Communications 2019 被引用: 121

  22. CRESTONE: Initial efficacy and safety of seribantumab in solid tumors harboring NRG1 fusions.

    著者: Daniel R. Carrizosa, Mark E. Burkard, Yasir Y. Elamin, Jayesh Desai, Shirish M. Gadgeel, Jessica Jiyeong Lin, Saiama N. Waqar, David R. Spigel, Young Kwang Chae, Parneet Cheema, Eric B. Haura, Stephen V. Liu, Danny Nguyen, Karen L. Reckamp, Frank Tsai, Valerie M. Jansen, Alexander Drilon, Sai‐Hong Ignatius Ou, D. Ross Camidge, Tejas Patil - Journal of Clinical Oncology 2022 被引用: 40

  23. Phase I Study of JNJ-74699157 in Patients with Advanced Solid Tumors Harboring the KRAS G12C Mutation

    著者: Judy Wang, Patricia Martín-Romano, Philippe A. Cassier, Melissa L. Johnson, Eric B. Haura, Laurie Lenox, Yue Guo, Nibedita Bandyopadhyay, Michael J. Russell, Elizabeth Shearin, Josh Lauring, Laëtitia Dahan - The Oncologist 2022 被引用: 55

  24. Phase IB Study of Osimertinib in Combination with Navitoclax in EGFR-mutant NSCLC Following Resistance to Initial EGFR Therapy (ETCTN 9903)

    著者: Erin M. Bertino, Ryan D. Gentzler, Sarah Clifford, Jill Kolesar, Alona Muzikansky, Eric B. Haura, Zofia Piotrowska, D. Ross Camidge, Thomas E. Stinchcombe, Christine Hann, Jyoti Malhotra, Liza C. Villaruz, Cloud P. Paweletz, Christie J. Lau, Lynette M. Sholl, Naoko Takebe, Jeffrey A. Moscow, Geoffrey I. Shapiro, Pasi A. Jänne, Geoffrey R. Oxnard - Clinical Cancer Research 2020 被引用: 43